Cyclacel Pharmaceuticals, Inc. - Common Stock (CYCC)
13.07
+4.84 (58.81%)
NASDAQ · Last Trade: Jul 19th, 8:02 PM EDT
Detailed Quote
Previous Close
8.230
Open
8.000
Bid
11.80
Ask
12.50
Day's Range
8.000 - 18.00
52 Week Range
0.2150 - 39.84
Volume
22,375,236
Market Cap
4.66B
PE Ratio (TTM)
72.61
EPS (TTM)
0.2
Dividend & Yield
2.400 (18.36%)
1 Month Average Volume
5,442,508
Chart
About Cyclacel Pharmaceuticals, Inc. - Common Stock (CYCC)
Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. The company leverages its proprietary drug development programs, which aim to address unmet medical needs in oncology, by targeting specific cancer cell cycle mechanisms and pathways. With a strong emphasis on research and development, Cyclacel is engaged in advancing its pipeline of therapeutic candidates towards clinical trials, seeking to bring new treatment options to patients with various types of cancer. Through its scientific expertise, the company strives to improve patient outcomes and contribute to the advancement of cancer care. Read More
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
